LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
11.49
-0.41 (-3.45%)
Aug 11, 2026, 3:25 PM EDT - Market open
LifeStance Health Group Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 225.94 | 248.64 | 154.57 | 78.82 | 108.62 | 148.03 |
Cash & Short-Term Investments | 225.94 | 248.64 | 154.57 | 78.82 | 108.62 | 148.03 |
Cash Growth | 19.59% | 60.86% | 96.10% | -27.43% | -26.62% | 686.18% |
Accounts Receivable | 110.96 | 95.71 | 131.8 | 125.41 | 100.87 | 76.08 |
Other Current Assets | 41.06 | 71.85 | 26.14 | 21.5 | 23.73 | 42.41 |
Total Current Assets | 377.97 | 416.2 | 312.51 | 225.73 | 233.22 | 266.52 |
Net Property, Plant & Equipment | 321.7 | 311.3 | 313.92 | 358.93 | 393.62 | 152.24 |
Other Intangible Assets | 172.81 | 177.67 | 190.8 | 221.07 | 263.29 | 300.36 |
Goodwill | 1,305 | 1,293 | 1,293 | 1,293 | 1,273 | 1,205 |
Other Long-Term Assets | 4.47 | 5.42 | 7.72 | 10.9 | 10.8 | 3.45 |
Total Assets | 2,181 | 2,204 | 2,118 | 2,110 | 2,174 | 1,927 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 11.05 | 6.12 | 7.24 | 7.05 | 12.29 | 14.15 |
Accrued Expenses | 198.87 | 185.51 | 164.4 | 137.49 | 106.08 | 86.51 |
Current Portion of Leases | 46.5 | 45.54 | 49.45 | 46.48 | 38.82 | - |
Other Current Liabilities | 18.33 | 14.78 | 7.79 | 11.86 | 18.81 | 16.09 |
Total Current Liabilities | 274.75 | 251.96 | 228.89 | 202.87 | 176 | 116.75 |
Long-Term Debt | 258.99 | 265.93 | 279.79 | 280.29 | 225.08 | 157.42 |
Long-Term Leases | 154.16 | 148.55 | 148.7 | 181.36 | 212.59 | - |
Other Long-Term Liabilities | 16.45 | 16.48 | 14.64 | 16.52 | 41.48 | 107.91 |
Total Long-Term Liabilities | 429.6 | 430.96 | 443.13 | 478.17 | 479.15 | 265.33 |
Total Liabilities | 704.35 | 682.92 | 672.01 | 681.04 | 655.15 | 382.08 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.82 | 3.88 | 3.83 | 3.79 | 3.76 | 3.74 |
Additional Paid-in Capital | 2,244 | 2,326 | 2,260 | 2,184 | 2,084 | 1,898 |
Accumulated Other Comprehensive Income | - | - | 0.93 | 2.3 | 3.27 | - |
Retained Earnings | -770.77 | -808.63 | -818.29 | -760.85 | -572.64 | -357.07 |
Total Common Shareholders' Equity | 1,477 | 1,521 | 1,446 | 1,429 | 1,519 | 1,545 |
Shareholders' Equity | 1,477 | 1,521 | 1,446 | 1,429 | 1,519 | 1,545 |
Total Liabilities & Equity | 2,181 | 2,204 | 2,118 | 2,110 | 2,174 | 1,927 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 459.65 | 460.02 | 477.94 | 508.12 | 476.49 | 157.42 |
Net Cash (Debt) | -233.71 | -211.38 | -323.37 | -429.29 | -367.87 | -9.39 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.60 | -0.54 | -0.85 | -1.17 | -1.03 | -0.03 |
Book Value | 1,477 | 1,521 | 1,446 | 1,429 | 1,519 | 1,545 |
Book Value Per Share | 3.77 | 3.89 | 3.81 | 3.89 | 4.27 | 4.72 |
Tangible Book Value | -0.21 | 50 | -37.86 | -85.49 | -17.51 | 40.13 |
Tangible Book Value Per Share | -0.00 | 0.13 | -0.10 | -0.23 | -0.05 | 0.12 |